Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Cimzia (certolizumab pegol) and Humira (adalimumab) are both injectable medications used to treat various autoimmune conditions, but they have some differences between them. Cimzia is typically given every 2 to 4 weeks, while Humira is usually administered every other week. Cimzia is not approved for use in children, while Humira can be used in children as young as 2 years old for certain conditions. Cimzia can be stored at room temperature for up to 7 days, but Humira can be kept at room temperature for up to 14 days. Both medications can raise your risk of serious infections. Currently Humira has more biosimilars available, which are similar versions of the medication.
Cimzia (certolizumab)
Humira (adalimumab)
Cimzia (certolizumab)
Humira (adalimumab)
Summary of Cimzia vs. Humira
Summary for TNF blocker
Prescription only
Cimzia (certolizumab) is a prescription biologic used to treat several autoimmune conditions, like rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. It works by blocking a protein called tumor necrosis factor (TNF), which helps reduce inflammation in your body. The medication is given as an injection under the skin every 2 to 4 weeks, depending on your condition. Common side effects include upper respiratory infections, urinary tract infections (UTIs), and skin rash.
Summary for Biologic DMARD
Prescription only
Humira (adalimumab) is an injectable medication used for treating many different autoimmune conditions, including rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis. It's usually given every other week, and it can be used alone or taken with methotrexate or other non-biologic medications. This medication is available as many different brands (or biosimilars).
Indications of Cimzia vs. Humira
Indications for
•Moderate-to-severe Crohn's disease when other treatments haven't worked - adults only